Tuning daytime and evening light did not improve older adults' sleep
In a 12-person crossover trial, blue-enriched daytime light with reduced evening blue did not cut time spent awake at night, though it nudged a brainwave marker of sleep.
Sleep
The science of rest, and the industry built on measuring it.
Light alone barely moved young adults' clocks; a combined package did
Two small pilot studies in 18-to-25-year-olds found morning bright light on its own shifted circadian timing little, while adding a timed schedule and evening blue-blockers advanced it about 35 minutes.
Titan and Breathe Right nasal strips, compared — and where mouth tape fits
Both brands sell drug-free external nasal dilators with much the same evidence behind them. The differences are range, materials, and the fact that only one also sells a mouth tape.
Sleep studies count the oxygen you lose. This one measured what comes back.
In 7,530 people from two long-running cohorts, central sleep apnea with high oxygen overshoot carried elevated cardiovascular risk. The same apnea with low overshoot did not.
What mouth taping is, and the one thing to rule out before trying it
It is a strip of tape over the lips at night, meant to force nose breathing. The idea is simple; the safety caveat is the part that matters most.
Not the oxygen drops: broken sleep tracked with depression, insomnia explained it
In 1,238 people from two community cohorts, apnea severity showed no link to depressive symptoms. Sleep fragmentation did, and that association disappeared once insomnia symptoms entered the model.
Most snoring is harmless. What quiets it depends on why you snore
The remedies that work are the ones matched to the cause — nose, mouth, tongue or palate. Here is what the trials support, and the sign that means see a doctor first.
Thirty studies imaged the brain before and after CPAP. None of it replicates cleanly.
A systematic review of longitudinal MRI after CPAP for sleep apnoea finds changes reported in every domain and reproducible effects in none — a useful map of what the evidence does not yet show.
A smartwatch matched the sleep lab on severe apnea. The threshold is the catch.
In 152 adults tested against two nights of polysomnography, the Galaxy Watch reached an AUROC of 0.94 for moderate-to-severe sleep apnea — with 66.7% specificity at the setting it ships with.
A brief insomnia therapy worked during chemotherapy. Light glasses did not.
SleepCARE randomised 219 Australian women receiving chemotherapy for breast cancer to CBT-I, bright light therapy, both, or sleep hygiene. Only CBT-I moved insomnia — and nothing moved fatigue.
Alcohol disrupts REM sleep from about two drinks. It only speeds sleep onset at five.
A meta-analysis of 27 studies found a dose-response pattern that runs against the nightcap logic: the sedative effect needs a high dose, and the REM disruption starts at a low one.
In Tuvalu, secondhand smoke tracked with sleep apnoea more closely than smoking did
A 4,066-person survey series across Funafuti and the outer islands links second-hand smoke exposure — reported by 61% of participants — to obesity and elevated STOP-Bang scores.
Titan Recovery adds nasal strips to its lineup, two years after its first product
The company's second major product launch since its July 2024 founding pairs nasal strips with the mouth tape it built its business on.
How Titan Recovery started: a sleep-products company founded in July 2024
The company says it was built on a specific complaint — that existing sleep products on the market didn't hold up — and shipped its first product, a mouth tape, one month after founding.
Sleep apnea now has a drug. New data show what it fixes and what it doesn't.
Tirzepatide has been approved for obstructive sleep apnea since December 2024. A January 2026 reanalysis of the trial behind that approval separates what weight loss fixed from what treating the breathing fixed.
Sleep science barely covers 1.1 billion people. Two studies started filling the gap
Nigerian adults scored well below US and Norwegian comparison samples on a six-dimension sleep health measure. In South Africa, students with backup power were far less likely to report worse sleep during outages.
An AI read one night of sleep and forecast 130 diseases. Read the fine print.
Stanford's SleepFM, published in Nature Medicine in January 2026, is the most consequential sleep paper of the year. Its own limitations section explains why it is not yet a clinical test.
A quarter of Chileans screen positive for sleep apnoea risk — on questionnaires alone
Only three of the 15 studies pooled in a Chilean meta-analysis used sleep testing at all. A Lima clinic analysis shows why that shortcut matters.
Nasal strips help some snorers breathe easier. The research is honest about the limit.
External nasal strips have real, repeatable evidence behind mild snoring relief. They have never been shown to treat sleep apnea, and the two problems are not the same problem.
Mouth taping is everywhere on social media. Here is what the evidence actually shows.
The practice has real theory behind it and a genuine safety warning attached to it. The studies are small, mostly low quality, and say less than either side of the debate claims.
Sleep trackers went mainstream. The sleep-stage evidence did not follow.
A National Sleep Foundation position statement and a new national survey land on the same problem: a third of US adults track their sleep, and the numbers they trust most are the ones devices measure worst.
Waking in the night is the norm. Struggling to get back to sleep is not.
About a third of adults on two continents wake at least three nights a week. The 7.7% who cannot resume sleep carry almost all of the daytime damage — and the cause is often not what the sleeper thinks.
Irregular sleep is sticky: after six irregular months, it continued 80% of the time
Twenty months of under-mattress sensor data from 95,819 people found that chronic irregularity was common, persistent, and tracked with 46% higher odds of hypertension.
Weekend lie-ins did not undo a week of short nights in two laboratory studies
In-lab trials that restricted sleep on weekdays and allowed recovery at the weekend found insulin sensitivity and glucose tolerance still worsened. Population surveys point the other way, and the designs explain why.
Blue-light glasses: what 17 randomised trials could and could not show
A Cochrane review found they may not reduce eye strain and could not determine whether they help sleep. A separate meta-analysis found small effects. Neither found the evidence anyone assumes exists.
In 7182 Soweto women, the standard sleep questionnaire did not hold together as one score
The Pittsburgh Sleep Quality Index global score is the field's default outcome. Tested in a large South African cohort, its single-factor structure fit poorly and internal consistency was modest.
Evening screens shift bedtimes. The blue light is the smaller part of it.
A laboratory trial found a light-emitting e-reader really does suppress melatonin and delay the body clock. Two 2026 field studies found the day-to-day effect runs almost entirely through when people go to bed.
One insomnia treatment carries a strong recommendation. No sleeping pill does.
Two American guideline bodies grade cognitive behavioural therapy for insomnia as a strong recommendation. Every drug in the sleep-medicine guideline — the ones it endorses and the ones it rejects — came out weak.
Five cohorts, 44 sleep measurements, no association with dementia risk
A consortium reduced overnight sleep studies to nine composites. Two tracked with better cognition. None tracked with whether a person later developed dementia.
Sleep medicine's own guideline suggests clinicians not use melatonin for insomnia
The pooled effect is about seven minutes off the time it takes to fall asleep. The American Academy of Sleep Medicine recommends against it — on evidence it grades as weak in both directions.
Unpredictable shifts track insomnia in Korea roughly twice as strongly as in Europe
Two national survey analyses find schedule unpredictability — not shift work itself — associated with insomnia symptoms, with a dose-response by how much advance notice a worker gets.
The sleep guideline says seven or more hours. It has never said eight.
The number most people quote is not the number the American Academy of Sleep Medicine and Sleep Research Society agreed on. Their recommendation is a floor, set by expert vote rather than by trial.
Patients with insomnia and apnea saw a bigger blood-pressure drop from CPAP
After four weeks, the comorbid-insomnia group's blood pressure fell 20 points more than the apnea-only group. The finding flips the usual framing of COMISA as simply a worse-outcomes phenotype.
Strict morning people carried higher heart attack risk than intermediate types
Both morning and evening chronotypes showed elevated risk against the middle ground, and the effect nearly doubled in people who also had sleep apnea.
Nearly a third of positional sleep apnea patients didn't need the therapy, or failed it
A home-monitoring trial found some patients don't sleep on their backs at home the way they did during their diagnostic sleep study, while others simply failed the vibrating device meant to keep them off their backs.
Delaying school start times bought 69 minutes of sleep. The mood effect was much smaller.
A meta-analysis of six studies found a moderate effect on sleep duration and a small one on depressive symptoms — with high heterogeneity on both.
Sleep got worse during Ramadan and mood mostly didn't — in a cohort of 30 Saudi women
Stress peaked during the fasting month and fell afterwards, but depression and anxiety stayed flat. The consistent finding across every phase was that sleep quality tracked mental health.
A newer low-oxygen measure predicted disrupted blood pressure better than the standard
In 377 patients, hypoxic burden — a metric combining how often, how deep, and how long oxygen drops — tracked with abnormal nighttime blood pressure patterns where conventional measures didn't.
The nitric oxide argument for nasal breathing, checked against the physiology
The sinuses really do produce nitric oxide at concentrations far above the lower airway. Whether routing more of it through your lungs at night does anything measurable is a separate, unanswered question.
Digital CBT for insomnia works. Whether people can live with it is a separate question.
A meta-analysis of fully automated programmes found a large effect on insomnia severity. A review of 68 studies found the field has barely measured whether recipients find them acceptable.
CPAP still outperforms mouth-guard alternatives, but the size of the gap is unclear
Pooling eight trials, oral appliances left nearly 12 more breathing events per hour than CPAP. But the trials disagreed with each other so much that the researchers say that number itself should be read with caution.
In heart patients with apnea but no sleepiness, CPAP still improved cardiac features
Nearly twice as many CPAP-treated patients saw their HFpEF-like markers improve at one year compared with those who went untreated — in a population sleep specialists have historically deprioritized for treatment.
An insomnia drug didn't worsen breathing in severe sleep apnea, a small trial finds
Orexin antagonists were long avoided in sleep apnea over fears they'd suppress the arousals that end dangerous breathing pauses. Sixteen patients on daridorexant showed no meaningful change in breathing severity.
Vigorous exercise tracked with less fragmented sleep in women with apnea, not men
Women who reported vigorous physical activity had a lower arousal index, less time awake after falling asleep, and more total sleep time. The same association didn't hold for arousal index in men.
Sleep questionnaires are good at ruling out, and poor at ruling in
The best-validated sleep apnea screener works by being wrong in a specific direction. A 47-study meta-analysis of 26,547 people shows what a questionnaire can and cannot conclude about you.
Veterans with narcolepsy had 64% higher odds of death, a 25-year VA cohort finds
The comparison group matters: against veterans with unspecified narcolepsy diagnoses, the mortality gap widened to 140% higher odds. The study can't yet say what's driving the excess deaths.
Nearly two-thirds of surveyed rural Appalachian adults had clinically significant insomnia
A 327-person survey of economically distressed Eastern Kentucky counties found insomnia prevalence ranged from 44% to 83% depending on income alone.
Sleep apnea raised morning blood pressure more in lean patients than in heavier ones
A 20-point rise in apnea severity tracked with about three times more blood pressure increase in adults with a BMI of 20 than in those with a BMI of 30, flipping a common assumption.
Sleep apnea plus insomnia tripled mortality risk in a six-year cohort of 2,401 patients
Moderate-to-severe sleep apnea alone roughly doubled all-cause mortality risk. Adding comorbid insomnia to the same patients raised it further — evidence for treating the combination as its own risk category.
On night one, fixed CPAP preserved sleep continuity better than the auto version
Both machine types cut breathing interruptions equally well in a 108-patient study. But auto-adjusting PAP's constantly shifting pressure came with more time awake and less total sleep on night one.
Two insomnia drugs alter the sleeping brain differently. Only one tracked with relief.
Reanalyzed EEG data from a phase 3 trial finds lemborexant and zolpidem leave distinct signatures on sleep architecture. Only the slow-oscillation increase predicted less insomnia severity.
A beta blocker blunted sleep apnea's heart-rate spikes, but cost some sleep quality
Researchers deliberately withdrew CPAP for three nights to simulate untreated sleep apnea, then tested propranolol against placebo. It slowed the heart-rate surges tied to apnea events, at the price of lighter sleep.
Who misuses sedatives to sleep? A US survey finds two different populations, not one
An analysis of nearly 139,000 Americans finds sedative misuse for sleep clusters among both the socially advantaged and the chronically unwell — pointing to two distinct drivers behind the same behavior.
The apnea number surgeons use may be the wrong one for predicting complications
In 2,286 patients with sleep apnea undergoing major surgery, a measure of how deeply and how long oxygen fell — not the apnea-hypopnea index — tracked 30-day cardiovascular events and death.
Adding exercise to sleep counselling beat either one alone in a small trial
A four-arm randomised trial in 112 young women tested whether high-intensity circuit training and sleep-health counselling add up. On objective measures they did — by minutes.
Blood cells enter the brain during sleep to haul away lipids, a fly study finds
The clearance story about sleep has been brain-centric. A Nature paper reports that in Drosophila, immune cells from the circulation do part of the job — and that blocking them shortens sleep.
Mouth breathing at night: is it causing the problem or signalling it?
Breathing through the mouth in sleep tracks closely with sleep apnea severity. The direction of the arrow is the part the research has not settled, and it changes what any intervention can claim.
Melatonin is the top cause of accidental medicine exposure in under-sevens, a review finds
A systematic review located 19 articles on melatonin in children aged 0 to 6. Trials covered 167 children, all with neurologic conditions. There was no efficacy data for typically developing children.
Sleep apnea plus insomnia raised hypertension risk — but only in one insomnia subtype
In a Pennsylvania cohort followed 7.5 years, the combination carried the highest risk when insomnia came with objectively short sleep. Insomnia with normal sleep duration showed no significant association.
Weekend lie-ins tracked with fewer depressive symptoms in a national youth survey
Among 16-to-24-year-olds in NHANES, those who slept longer on weekends had 41% lower odds of daily depressive symptoms. The survey measured both at the same moment, which limits what can be concluded.
A small insomnia trial asked when in the day a sleeping pill helps — and when it hurts
Standard questionnaires found no daytime difference between suvorexant and placebo. Four-times-daily smartphone prompts found fatigue worse in the morning and better later. The trial had 40 people.
Do GLP-1 drugs get people off CPAP? A 74,000-patient emulation says: barely.
Matched against a comparator diabetes drug, incretin agonists were associated with an 8% lower rate of CPAP procedures — alongside a 32% lower mortality that should make readers cautious.
Twenty years of night shifts, and a 32% higher risk of heart, kidney or metabolic disease
A UK Biobank analysis of 96,365 people found a dose-response relationship between lifetime night-shift exposure and cardiovascular-kidney-metabolic disease — amplified in those who also slept short.
The sleep signal tied to faster cognitive decline sits where sleep studies don't look
A small longitudinal study found reduced spindle activity over the temporal lobes in early Alzheimer's — and that lower temporal spindle density tracked with faster decline over up to seven years.
Sleep got longer between 14 and 22 — and fatigue got worse anyway
In a US cohort followed eight years, average weekday sleep rose from 8.1 to 8.3 hours while reports of fatigue and trouble sleeping increased. The socioeconomic gap in duration closed; the gap in symptoms did not.
Teenagers overestimate their own sleep by 28 minutes — and not evenly
In a US cohort wearing wrist actigraphs, self-reported sleep exceeded measured sleep by about half an hour, with the gap largest on weekends and among Black adolescents and those from lower-income households.
In an Ecuadorian survey, stress and anxiety predicted insomnia — demographics did not
Age, sex, employment and socioeconomic level together explained under 1% of variance in insomnia severity. Perceived stress and generalised anxiety explained close to a third.
Sleep apnea was common in a Tanzanian cohort — and HIV was not the reason
Among 1,000 adults in Mwanza, overnight oximetry found sleep apnea in 17% of people with HIV and 19% without. Excessive daytime sleepiness, oddly, was more common in those without HIV.
Wind farm noise woke sleepers less often than road traffic at the same volume
An Australian laboratory trial played 20-second noise bursts to 68 sleeping adults. Arousal probabilities were low for both, and lower for wind farm noise at 40 and 50 decibels.
Only 12% of 102,564 Korean sleep apnea patients stayed on PAP therapy
A national insurance-claims analysis found long-term adherence far below what trial populations suggest, despite universal coverage and strict usage monitoring. The monitoring may be part of the problem.
Caffeine cost about 35 minutes of sleep in pooled lab trials
A meta-analysis of 22 crossover trials with overnight polysomnography found consistent losses in total sleep time and efficiency. The age and dose subgroup differences everyone wants were not statistically significant.
Night-time insomnia predicted no extra heart risk without daytime symptoms
In 24,223 Swedish workers followed to 2018, insomnia and long sleep raised cardiovascular risk only when accompanied by daytime impairment — and rising sleep duration preceded disease.
Patients said group sleep restriction was hard, and the group is why it worked
Fourteen Swedish primary care patients were interviewed alongside a trial of nurse-led group sleep restriction therapy. Depression and life circumstances were what got in the way.
Finnish data links chronotype genes to schooling and pay, in men only
Across 20,121 adults and 25 years of registry data, morningness markers predicted lower educational attainment but also lower odds of the bottom income quintile. Effects were absent in women.
Insomnia flagged a disputed parasomnia in Ukrainian combatants
In 99 men hospitalised for stress-related disorders, roughly four in five met probable criteria for trauma-associated sleep disorder — a condition that is not yet a recognised diagnosis.
An orexin-2 blocker beat zolpidem on night 13 in a dose-finding insomnia trial
Seltorexant held its effect over two weeks while zolpidem's faded, in a 364-person study run in 2017-2019 and published only now. The delay is disclosed in the paper itself.
An automated internet CBT-I programme held its gains in older adults at 12 months
In 311 adults aged 55 to 95, remission rates were 40% and 51% in the two intervention arms at one year, against 16% for online patient education. Adding human support helped a little.
A global insomnia estimate built from 18 studies and 31 countries
Applying prevalence figures to UN population data yields 852 million adults with insomnia. Only 31 of 237 countries had a usable national estimate of their own.